Glen Harbor Capital Management’s Pfizer PFE Stock Holding History

Glen Harbor Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$10.8M	Sell	315,795 -62,178	-16%	-$2.26M	0.22%	93
2019 Q2	$15.5M	Sell	377,973 -34,790	-8%	-$1.38M	0.32%	67
2019 Q1	$16.6M	Buy	412,763 +31,350	+8%	+$1.26M	0.36%	61
2018 Q4	$15.8M	Buy	381,413 +38,585	+11%	+$1.6M	0.38%	58
2018 Q3	$14.3M	Buy	342,828 +27,910	+9%	+$1.07M	0.29%	86
2018 Q2	$10.8M	Buy	314,918 +13,204	+4%	+$451K	0.23%	97
2018 Q1	$10.2M	Buy	301,714 +34,420	+13%	+$1.18M	0.23%	96
2017 Q4	$9.19M	Buy	267,294 +50,558	+23%	+$1.72M	0.21%	99
2017 Q3	$7.34M	Buy	216,736 +35,718	+20%	+$1.15M	0.18%	114
2017 Q2	$5.77M	Buy	181,018 +39,462	+28%	+$1.24M	0.14%	145
2017 Q1	$4.59M	Buy	141,556 +41,772	+42%	+$1.32M	0.11%	168
2016 Q4	$3.08M	Buy	+99,784	New	+$3.05M	0.08%	199

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Glen Harbor Capital Management's PFE Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Pfizer (PFE) stake by 16% in Q3 2019, selling an estimated $2.26M and leaving 315,795 shares worth $10.8M. The position accounts for 0.22% of the portfolio, ranked #93.

Glen Harbor Capital Management first reported a position in PFE in Q4 2016 and has held it in 12 quarters since. The position peaked at $16.6M in Q1 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Glen Harbor Capital Management held 315,795 shares of Pfizer worth $10.8M as of Q3 2019.
Glen Harbor Capital Management sold 62,178 Pfizer shares in Q3 2019, an estimated $2.26M.
Pfizer made up 0.22% of Glen Harbor Capital Management's portfolio in Q3 2019, its #93 holding.
Glen Harbor Capital Management first reported a position in Pfizer in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Pfizer position peaked at $16.6M in Q1 2019.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.